|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000863131 |
| 003 |
SK-MaSNL |
| 005 |
20260304222450.0 |
| 008 |
140303c2003 xo 0 slo |
| 015 |
|
|
|a SNBRB2004/02-05442
|
| 035 |
|
|
|a CLN000214696
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.24-006.6-085:615.277
|2 1997
|
| 080 |
|
|
|a 618.19-006.6-085:615.277
|2 1997
|
| 245 |
0 |
0 |
|a Sympózium spoločnosti AstraZeneca
|
| 300 |
|
|
|b Grafy, obr.
|
| 610 |
2 |
7 |
|a AstraZeneca Slovakia (firma)
|2 SNKKA
|9 33616
|
| 648 |
|
7 |
|a 2003
|2 SNK
|9 301018
|
| 650 |
0 |
7 |
|a pľúca
|2 snkbucl
|9 16489
|
| 650 |
0 |
7 |
|a prsníky
|2 snkbucl
|9 67661
|
| 650 |
0 |
7 |
|a karcinóm nemalobunkový
|2 snkbucl
|9 1436358
|
| 650 |
0 |
7 |
|a karcinóm
|2 snkbucl
|9 900579
|
| 650 |
0 |
7 |
|a goserelín
|2 snkbucl
|9 1387985
|
| 650 |
0 |
7 |
|a tamoxifen
|2 snkbucl
|9 897292
|
| 650 |
0 |
7 |
|a gefitinib
|2 snkbucl
|9 871575
|
| 650 |
0 |
7 |
|a nádory prsníka
|2 MESH
|9 22917
|
| 650 |
0 |
7 |
|a karcinóm pľúcny nemalobunkový
|2 MESH
|9 1185694
|
| 650 |
0 |
7 |
|a sympóziá
|2 SNKPH
|9 22177
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 773 |
0 |
|
|t Príloha ZdN
|g Č. 42 (2003), s. 23-27
|x 1335-4477
|
| 773 |
0 |
|
|t Zdravotnícke noviny
|g Roč. 8, č. 42 (2003)
|x 1335-4477
|
| 850 |
|
|
|a Slovenská národná knižnica v Martine
|
| 852 |
|
|
|a SNK
|b KIS3GCP
|
| 958 |
|
|
|a SK
|
| 958 |
|
|
|a MI
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 3163421
|d 3165351
|
